CONTEGRA PULMONARY VALVED CONDUIT 200S

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,literatur report with the FDA on 2020-01-02 for CONTEGRA PULMONARY VALVED CONDUIT 200S manufactured by Medtronic Heart Valves Division.

Event Text Entries

[182589938] Citation: mastropietro cw et al. Characteristics and operative outcomes for children undergoing repair of truncus arteriosus: a contemporary multicenter analysis. J thorac cardiovasc surg. 2019 jun;157(6):2386-2398. E4. Doi: 10. 1016/j. Jtcvs. 2018. 12. 115. Epub 2019 feb 28. Read at the 98th annual meeting of the american association for thoracic surgery, san diego, california, april 28-may 1, 2018. Earliest date of publish used for event date. No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported. Without return of the product no definitive conclusion can be made regarding the clinical observations. (b)(4). If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[182589939] Medtronic received information via literature regarding the outcomes of pediatric patients who underwent truncus arteriosus repair and the risk factors for post-operative major adverse cardiac events. All data were retrospectively collected from 15 centers between 2009 and 2016. The study population included 216 patients and was equal numbers male and female with a mean age of 10 days, mean weight of 3. 1 kg and predominant race of white non-hispanic. Of those, 55 were implanted with medtronic contegra valved conduits. No serial numbers were provided. Among all patients, the operative mortality was 6. 9% (15 patients). No other details were reported. Based on the available information, medtronic product was not directly associated with the deaths. Among all patients, adverse events included: unplanned reoperation for bleeding; unplanned cardiac catheterizations; unplanned truncal valve repair or replacement; unplanned right ventricle-to-pulmonary artery conduit revision; unplanned sternal closure; stroke; cardiac arrest; cardiopulmonary resuscitation; extracorporeal membrane oxygenation support; inhaled nitric oxide use; bradyarrhythmia; tachyarrhythmia that required medication or temporary pacing; sepsis/bacteremia; endocarditis; mediastinitis; wound infection/dehiscence; and seizures. Based on the available information, medtronic product may have been associated with the adverse events. No additional adverse patient effects or product performance issues were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2025587-2020-00013
MDR Report Key9540896
Report SourceHEALTH PROFESSIONAL,LITERATUR
Date Received2020-01-02
Date of Report2020-01-14
Date of Event2018-04-28
Date Mfgr Received2020-01-10
Date Added to Maude2020-01-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPAULA BIXBY
Manufacturer Street8200 CORAL SEA STREET NE
Manufacturer CityMOUNDS VIEW MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone7635055378
Manufacturer G1MEDTRONIC HEART VALVES DIVISION
Manufacturer Street1851 E DEERE AVE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal Code92705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCONTEGRA PULMONARY VALVED CONDUIT
Generic NameCONDUIT,VALVED,PULMONIC
Product CodeMWH
Date Received2020-01-02
Model Number200S
Catalog Number200S
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC HEART VALVES DIVISION
Manufacturer Address1851 E DEERE AVE SANTA ANA CA 92705 US 92705


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.